glp-1 receptor agonists and cardiovascular outcome trials an update Effects of on cardiometabolic outcomes in heart transplant recipients: A systematic review meta-analysis of observational studies The Many Cardiovascular Benefits of
Description
Heart Failure Benefits The most significant recent advancement has been the demonstration of profound benefits in heart failure with preserved ejection fraction (HFpEF) across multiple pivotal trials, establishing GLP-1 RAs as transformative therapy for obesity-related heart failure (Table 7)

doi: 10.1016/j.bbr.2019.111932 85 WangXWangLJiangRXuYZhaoXLiY

Insulin is a relatively large peptide

Yes, but do it tactfully
